Atopic dermatitis laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Atopic dermatitis}} | {{Atopic dermatitis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{S.S}} | ||
{{S.S}} | |||
==Overview== | ==Overview== | ||
| Line 12: | Line 10: | ||
* The most common laborotory finding in atopic dermatitis is an elevated total and/or allergen-specific serum IgE level, which is not present in about 20% of affected individuals.<ref name="pmid23473856">{{cite journal |vauthors=Kabashima K |title=New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity |journal=J. Dermatol. Sci. |volume=70 |issue=1 |pages=3–11 |date=April 2013 |pmid=23473856 |doi=10.1016/j.jdermsci.2013.02.001 |url=}}</ref> | * The most common laborotory finding in atopic dermatitis is an elevated total and/or allergen-specific serum IgE level, which is not present in about 20% of affected individuals.<ref name="pmid23473856">{{cite journal |vauthors=Kabashima K |title=New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity |journal=J. Dermatol. Sci. |volume=70 |issue=1 |pages=3–11 |date=April 2013 |pmid=23473856 |doi=10.1016/j.jdermsci.2013.02.001 |url=}}</ref> | ||
* Monitoring of IgE levels is not recommended for the assessment of atopic dermatitis severity. | * Monitoring of IgE levels is not recommended for the assessment of atopic dermatitis severity. | ||
* Some of new biomarkers using the SCORing Atopic Dermatitis (SCORAD) index and other severity scales<ref name="pmid17047294">{{cite journal |vauthors=Aral M, Arican O, Gul M, Sasmaz S, Kocturk SA, Kastal U, Ekerbicer HC |title=The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis |journal=Mediators Inflamm. |volume=2006 |issue=4 |pages=73098 |date=2006 |pmid=17047294 |pmc=1618943 |doi=10.1155/MI/2006/73098 |url=}}</ref> | * Some of new biomarkers using the SCORing Atopic Dermatitis (SCORAD) index and other severity scales<ref name="pmid17047294">{{cite journal |vauthors=Aral M, Arican O, Gul M, Sasmaz S, Kocturk SA, Kastal U, Ekerbicer HC |title=The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis |journal=Mediators Inflamm. |volume=2006 |issue=4 |pages=73098 |date=2006 |pmid=17047294 |pmc=1618943 |doi=10.1155/MI/2006/73098 |url=}}</ref><ref name="pmid12775363">{{cite journal |vauthors=Di Lorenzo G, Gangemi S, Merendino RA, Minciullo PL, Cannavò SP, Martinelli N, Mansueto P, Rini GB, Corrocher R, Pacor ML |title=Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index |journal=Mediators Inflamm. |volume=12 |issue=2 |pages=123–5 |date=April 2003 |pmid=12775363 |pmc=1781600 |doi=10.1080/0962935031000097736 |url=}}</ref> | ||
** Serum levels of CD30 | ** Serum levels of CD30 | ||
** Macrophage-derived chemoattractant (MDC) | ** Macrophage-derived chemoattractant (MDC) | ||
Revision as of 16:47, 11 October 2018
|
Atopic dermatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Atopic dermatitis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Atopic dermatitis laboratory findings |
|
Risk calculators and risk factors forAtopic dermatitis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shalinder Singh, M.B.B.S.[2]
Overview
There diagnosis of atopic dermatitis remains clinical as there is no reliable bio-marker that can differentiate the atopic dermatitis from other skin diseases.
Laboratory Findings
- There are no reliable diagnostic laboratory findings associated with atopic dermatitis.
- The most common laborotory finding in atopic dermatitis is an elevated total and/or allergen-specific serum IgE level, which is not present in about 20% of affected individuals.[1]
- Monitoring of IgE levels is not recommended for the assessment of atopic dermatitis severity.
- Some of new biomarkers using the SCORing Atopic Dermatitis (SCORAD) index and other severity scales[2][3]
- Serum levels of CD30
- Macrophage-derived chemoattractant (MDC)
- Interleukins (IL)-12
- Interleukins (IL)-16
- Interleukins (IL)-18
- Interleukins (IL)-31
- Thymus and activation-regulated chemokine (TARC)
References
- ↑ Kabashima K (April 2013). "New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity". J. Dermatol. Sci. 70 (1): 3–11. doi:10.1016/j.jdermsci.2013.02.001. PMID 23473856.
- ↑ Aral M, Arican O, Gul M, Sasmaz S, Kocturk SA, Kastal U, Ekerbicer HC (2006). "The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis". Mediators Inflamm. 2006 (4): 73098. doi:10.1155/MI/2006/73098. PMC 1618943. PMID 17047294.
- ↑ Di Lorenzo G, Gangemi S, Merendino RA, Minciullo PL, Cannavò SP, Martinelli N, Mansueto P, Rini GB, Corrocher R, Pacor ML (April 2003). "Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index". Mediators Inflamm. 12 (2): 123–5. doi:10.1080/0962935031000097736. PMC 1781600. PMID 12775363.